Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

Targeted therapies for cutaneous T-cell lymphoma (CTCL) are limited and curative approaches are lacking. Furthermore, relapses and drug induced side effects are major challenges in the therapeutic management of patients with CTCL, creating an urgent need for new and effective therapies. Pathologic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolay, Jan P., Melchers, Susanne, Albrecht, Jana D., Assaf, Chalid, Dippel, Edgar, Stadler, Rudolf, Wehkamp, Ulrike, Wobser, Marion, Zhao, Jing, Burghaus, Ina, Schneider, Sven, Gülow, Karsten, Goerdt, Sergij, Schürch, Christian M., Utikal, Jochen S., Krammer, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644069/
https://www.ncbi.nlm.nih.gov/pubmed/37217183
http://dx.doi.org/10.1182/blood.2022018669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644069/
https://www.ncbi.nlm.nih.gov/pubmed/37217183
http://dx.doi.org/10.1182/blood.2022018669

Ejemplares similares